RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $52,713,479.44

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$142.51

▼ -8.56 (-5.67%)

As of 05/7/2026 04:00 PM ET

Days: 30 | 90 | 365

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/15/2026	Mark A. Goldsmith	Insider	Sell	120,000	$150.09	$18,010,800.00	276,698
3/17/2026	Jack Anders	CFO	Sell	2,753	$99.48	$273,868.44	125,512
3/17/2026	Lin Wei	Insider	Sell	2,073	$99.48	$206,222.04	101,366
3/17/2026	Margaret A. Horn	COO	Sell	4,583	$99.48	$455,916.84	157,570
3/17/2026	Mark A. Goldsmith	Insider	Sell	12,871	$99.48	$1,280,407.08	276,698
3/17/2026	Stephen Michael Kelsey	Insider	Sell	4,302	$99.48	$427,962.96	295,398
3/17/2026	Xiaolin Wang	Insider	Sell	2,010	$99.48	$199,954.80	116,063
3/2/2026	Mark A. Goldsmith	Insider	Sell	30,000	$101.22	$3,036,600.00	289,569
3/2/2026	Mark A. Goldsmith	Insider	Sell	6,000	$101.30	$607,800.00	64,424
1/7/2026	Jack Anders	CFO	Sell	10,000	$98.00	$980,000.00	108,065
1/7/2026	Margaret A. Horn	COO	Sell	75,000	$100.56	$7,542,000.00	141,053
12/16/2025	Jack Anders	CFO	Sell	3,104	$77.09	$239,287.36	108,065
12/16/2025	Margaret A. Horn	COO	Sell	4,847	$76.82	$372,346.54	141,053
12/16/2025	Mark A. Goldsmith	Insider	Sell	15,394	$76.82	$1,182,567.08	232,469
12/16/2025	Stephen Michael Kelsey	Insider	Sell	5,447	$76.82	$418,438.54	278,600
11/25/2025	Mark A. Goldsmith	Insider	Sell	60,000	$75.08	$4,504,800.00	247,863
11/18/2025	Mark A. Goldsmith	Insider	Sell	20,000	$70.38	$1,407,600.00	247,863
11/12/2025	Mark A. Goldsmith	Insider	Sell	20,000	$65.07	$1,301,400.00	247,863
11/7/2025	Mark A. Goldsmith	Insider	Sell	30,000	$60.31	$1,809,300.00	347,863
10/13/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$48.54	$1,213,500.00	284,047
9/16/2025	Jack Anders	CFO	Sell	2,320	$45.82	$106,302.40	110,994
9/16/2025	Lin Wei	Insider	Sell	2,160	$45.82	$98,971.20	88,339
9/16/2025	Margaret A. Horn	COO	Sell	4,775	$45.82	$218,790.50	145,900
9/16/2025	Mark A. Goldsmith	Insider	Sell	13,411	$45.82	$614,492.02	452,309
9/16/2025	Stephen Michael Kelsey	Insider	Sell	5,367	$45.82	$245,915.94	284,047
9/15/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$45.97	$1,149,250.00	289,414
9/11/2025	Stephen Michael Kelsey	Insider	Sell	100,000	$44.08	$4,408,000.00	289,414
9/3/2025	Jack Anders	CFO	Sell	5,238	$40.17	$210,410.46	113,314
9/2/2025	Jack Anders	CFO	Sell	4,762	$40.02	$190,575.24	113,314
3/17/2025	Jack Anders	CFO	Sell	1,864	$39.04	$72,770.56	115,006
3/17/2025	Margaret A. Horn	COO	Sell	3,058	$39.04	$119,384.32	153,533
3/17/2025	Mark A. Goldsmith	Insider	Sell	11,738	$39.04	$458,251.52	441,564
12/16/2024	Jack Anders	CFO	Sell	2,635	$45.40	$119,629.00	96,470
12/16/2024	Margaret A. Horn	COO	Sell	4,329	$45.40	$196,536.60	127,991
12/16/2024	Mark A. Goldsmith	Insider	Sell	11,714	$45.40	$531,815.60	325,056
12/5/2024	Thilo Schroeder	Director	Buy	1,304,347	$46.00	$59,999,962.00	2,096,612
10/14/2024	Stephen Michael Kelsey	Insider	Sell	16,666	$49.49	$824,800.34	264,408
10/11/2024	Jack Anders	CFO	Sell	10,000	$50.30	$503,000.00	98,932
10/11/2024	Jeff Cislini	General Counsel	Sell	6,000	$50.17	$301,020.00	45,634
10/11/2024	Margaret A. Horn	COO	Sell	50,000	$50.34	$2,517,000.00	132,320
10/11/2024	Mark A. Goldsmith	Insider	Sell	30,000	$50.36	$1,510,800.00	300,170
10/8/2024	Barbara Weber	Director	Sell	5,200	$48.02	$249,704.00	13,065
10/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$44.93	$449,300.00	300,170
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013
9/18/2023	Jack Anders	CFO	Sell	1,427	$31.31	$44,679.37	53,667
9/18/2023	Jeff Cislini	General Counsel	Sell	1,214	$31.31	$38,010.34	42,013
9/18/2023	Margaret A. Horn	COO	Sell	2,514	$31.31	$78,713.34	96,960
9/18/2023	Stephen Michael Kelsey	Insider	Sell	2,060	$31.31	$64,498.60	290,388
9/15/2023	Margaret A. Horn	COO	Sell	5,000	$32.08	$160,400.00	99,474
9/1/2023	Barbara Weber	Director	Sell	15,000	$35.07	$526,050.00	15,825
9/1/2023	Jack Anders	CFO	Sell	20,000	$35.05	$701,000.00	55,094
9/1/2023	Mark A. Goldsmith	Insider	Sell	30,000	$35.05	$1,051,500.00	357,386
8/31/2023	Margaret A. Horn	COO	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Margaret A. Horn	COO	Sell	5,000	$30.53	$152,650.00	99,474
8/1/2023	Stephen Michael Kelsey	Insider	Sell	16,666	$29.19	$486,480.54	309,114
7/31/2023	Jeff Cislini	General Counsel	Sell	1,500	$26.02	$39,030.00	43,227
6/20/2023	Jack Anders	CFO	Sell	1,249	$24.89	$31,087.61	55,094
6/20/2023	Jeff Cislini	General Counsel	Sell	1,239	$25.14	$31,148.46	44,727
6/20/2023	Stephen Michael Kelsey	Insider	Sell	2,102	$24.89	$52,318.78	325,780

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2026	Meeder Advisory Services Inc.	4,126	$0.40M	0.0%	+3.0%	0.002%
5/7/2026	WCM Investment Management LLC	104,989	$9.73M	0.0%	-10.4%	0.049%
5/7/2026	Dimensional Fund Advisors LP	844,614	$82.07M	0.0%	-27.3%	0.397%
5/7/2026	Parallel Advisors LLC	562	$55K	0.0%	+181.0%	0.000%
5/7/2026	KBC Group NV	15,395	$1.50M	0.0%	+266.6%	0.007%
5/7/2026	SEB Asset Management AB	69,630	$6.77M	0.0%	N/A	0.033%
5/7/2026	Swiss National Bank	425,431	$41.37M	0.0%	+54.0%	0.200%
5/6/2026	Jennison Associates LLC	307,377	$29.89M	0.0%	+0.7%	0.145%
5/6/2026	California Public Employees Retirement System	281,960	$27.42M	0.0%	-3.1%	0.133%
5/6/2026	Financiere des Professionnels Fonds d investissement inc.	10,506	$1.02M	0.1%	N/A	0.005%
5/6/2026	Bessemer Group Inc.	48,062	$4.68M	0.0%	-59.2%	0.023%
5/5/2026	Beaumont Financial Advisors LLC	9,800	$0.95M	0.1%	-6.8%	0.005%
5/5/2026	Bank of New York Mellon Corp	635,366	$61.79M	0.0%	+17.2%	0.299%
5/5/2026	Livforsakringsbolaget Skandia Omsesidigt	1,000	$97K	0.0%	N/A	0.000%
5/5/2026	Zweig DiMenna Associates LLC	8,287	$0.81M	0.1%	-92.1%	0.004%
5/5/2026	Sanctuary Advisors LLC	2,195	$0.21M	0.0%	N/A	0.001%
5/4/2026	Calamos Advisors LLC	15,463	$1.50M	0.0%	+24.1%	0.007%
5/4/2026	Principal Financial Group Inc.	4,567	$0.44M	0.0%	-3.6%	0.002%
5/4/2026	J. Safra Sarasin Holding AG	21,001	$2.04M	0.0%	+170.4%	0.010%
5/4/2026	Teachers Retirement System of The State of Kentucky	10,824	$1.05M	0.0%	-10.5%	0.005%
5/1/2026	General American Investors Co. Inc.	62,545	$6.08M	0.4%	-2.3%	0.029%
5/1/2026	Fifth Third Bancorp	9,708	$0.94M	0.0%	+8,972.9%	0.005%
5/1/2026	Candriam S.C.A.	580,677	$56.47M	0.3%	-43.7%	0.273%
4/30/2026	Hsbc Holdings PLC	32,791	$3.19M	0.0%	+1,055.4%	0.015%
4/30/2026	Sumitomo Mitsui Trust Group Inc.	270,972	$26.35M	0.0%	+4,828.6%	0.137%
4/30/2026	Resona Asset Management Co. Ltd.	41,680	$4.02M	0.0%	N/A	0.021%
4/28/2026	Abel Hall LLC	5,842	$0.57M	0.1%	+6.1%	0.003%
4/28/2026	Praxis Investment Management Inc.	5,402	$0.53M	0.0%	+16.7%	0.003%
4/28/2026	QRG Capital Management Inc.	6,140	$0.60M	0.0%	N/A	0.003%
4/27/2026	HB Wealth Management LLC	3,110	$0.30M	0.0%	N/A	0.002%
4/27/2026	Private Advisor Group LLC	9,967	$0.97M	0.0%	-25.8%	0.005%
4/27/2026	Fjarde AP Fonden Fourth Swedish National Pension Fund	46,900	$4.56M	0.0%	N/A	0.024%
4/27/2026	Fideuram Intesa Sanpaolo Private Banking S.P.A.	9,031	$0.88M	0.0%	N/A	0.005%
4/25/2026	Strs Ohio	4,068	$0.40M	0.0%	-2.0%	0.002%
4/24/2026	IFM Investors Pty Ltd	28,809	$2.80M	0.0%	N/A	0.015%
4/22/2026	Janney Montgomery Scott LLC	2,472	$0.24M	0.0%	N/A	0.001%
4/22/2026	Citrine Capital LLC	2,501	$0.24M	0.1%	N/A	0.001%
4/22/2026	Pictet Asset Management Holding SA	557,560	$53.59M	0.1%	-51.0%	0.281%
4/22/2026	Sterling Capital Management LLC	11,343	$1.10M	0.0%	-46.7%	0.006%
4/21/2026	Cannon Global Investment Management LLC	8,500	$0.83M	1.6%	N/A	0.004%
4/21/2026	Aaron Wealth Advisors LLC	2,426	$0.24M	0.0%	N/A	0.001%
4/20/2026	Ritholtz Wealth Management	3,725	$0.36M	0.0%	N/A	0.002%
4/20/2026	OP Asset Management Ltd	33,633	$3.27M	0.0%	N/A	0.017%
4/17/2026	PKO Investment Management Joint Stock Co	1,500	$0.15M	0.0%	N/A	0.001%
4/16/2026	SG Americas Securities LLC	53,426	$5.20M	0.0%	+219.5%	0.027%
4/16/2026	E. Ohman J or Asset Management AB	4,000	$0.39M	0.0%	N/A	0.002%
4/16/2026	BI Asset Management Fondsmaeglerselskab A S	4,646	$0.45M	0.0%	N/A	0.002%
4/16/2026	Lunate Capital Ltd	549,050	$53.40M	44.7%	-75.0%	0.277%
3/20/2026	Hsbc Holdings PLC	2,838	$0.23M	0.0%	-98.5%	0.001%
3/17/2026	Rockefeller Capital Management L.P.	598	$48K	0.0%	+82.9%	0.000%
3/16/2026	Avoro Capital Advisors LLC	2,170,000	$172.84M	1.7%	N/A	1.095%
3/9/2026	Corient Private Wealth LLC	2,698	$0.22M	0.0%	N/A	0.001%
3/9/2026	Flax Pond Capital LLC	7,933	$0.63M	0.5%	N/A	0.004%
2/26/2026	Seven Fleet Capital Management LP	65,800	$5.24M	4.0%	N/A	0.034%
2/19/2026	T. Rowe Price Investment Management Inc.	2,200,376	$175.26M	0.1%	-54.0%	1.138%
2/19/2026	Invesco Ltd.	367,851	$29.30M	0.0%	+83.1%	0.190%
2/19/2026	Corient Private Wealth LLC	2,698	$0.22M	0.0%	N/A	0.001%
2/18/2026	ADAR1 Capital Management LLC	145,079	$11.56M	0.8%	+4.3%	0.075%
2/18/2026	Empowered Funds LLC	973	$77K	0.0%	N/A	0.001%
2/18/2026	KVP Capital Advisors LP	27,500	$2.19M	2.1%	N/A	0.014%
2/18/2026	XTX Topco Ltd	6,939	$0.55M	0.0%	N/A	0.004%
2/18/2026	VARCOV Co.	6,532	$0.52M	0.2%	N/A	0.003%
2/18/2026	Voloridge Investment Management LLC	322,289	$25.67M	0.1%	+116.1%	0.167%
2/18/2026	Vestal Point Capital LP	295,000	$23.50M	0.8%	-53.2%	0.153%
2/18/2026	Virtus Investment Advisers LLC	3,371	$0.27M	0.1%	+21.8%	0.002%
2/18/2026	Wellington Management Group LLP	6,987,639	$556.57M	0.2%	-28.8%	3.615%
2/18/2026	Tang Capital Management LLC	15,640	$1.25M	0.1%	-84.4%	0.008%
2/18/2026	Tudor Investment Corp ET AL	92,391	$7.36M	0.0%	N/A	0.048%
2/18/2026	Twinbeech Capital LP	2,700	$0.22M	0.0%	N/A	0.001%
2/18/2026	Sphera Funds Management LTD.	52,500	$4.18M	0.8%	-12.5%	0.027%
2/18/2026	Superstring Capital Management LP	54,879	$4.37M	2.3%	N/A	0.028%
2/18/2026	Orbimed Advisors LLC	25,900	$2.06M	0.0%	N/A	0.013%
2/18/2026	Oxford Asset Management LLP	4,888	$0.39M	0.2%	N/A	0.003%
2/18/2026	Man Group plc	97,505	$7.77M	0.0%	+1,526.7%	0.050%
2/18/2026	Janus Henderson Group PLC	12,303,502	$980.04M	0.4%	+8.3%	6.364%
2/18/2026	Gotham Asset Management LLC	113,829	$9.07M	0.0%	+14.8%	0.059%
2/18/2026	Engineers Gate Manager LP	13,456	$1.07M	0.0%	-55.7%	0.007%
2/18/2026	Casdin Capital LLC	2,577,333	$205.29M	12.8%	-2.6%	1.333%
2/18/2026	Cinctive Capital Management LP	42,635	$3.40M	0.2%	N/A	0.022%
2/18/2026	Aristotle Atlantic Partners LLC	10,410	$0.83M	0.0%	N/A	0.005%
2/18/2026	BVF Inc. IL	3,356,782	$267.37M	9.0%	-15.6%	1.736%
2/17/2026	Guggenheim Capital LLC	29,982	$2.39M	0.0%	-1.3%	0.016%
2/17/2026	Caligan Partners LP	1,283,900	$102.26M	8.4%	+20.6%	0.664%
2/17/2026	ADAR1 Capital Management LLC	145,079	$11.56M	0.8%	+4.3%	0.075%
2/17/2026	J. Goldman & Co LP	10,179	$0.81M	0.0%	-29.1%	0.005%
2/17/2026	AQR Capital Management LLC	127,170	$10.13M	0.0%	+80.9%	0.066%
2/17/2026	Abel Hall LLC	5,508	$0.44M	0.1%	N/A	0.003%
2/17/2026	MPM Bioimpact LLC	505,672	$40.28M	4.6%	+60.2%	0.262%
2/17/2026	Laird Norton Wetherby Trust Company LLC	4,729	$0.38M	0.0%	N/A	0.002%
2/17/2026	Paradigm Biocapital Advisors LP	6,644,403	$529.23M	13.5%	+6.8%	3.437%
2/17/2026	Trexquant Investment LP	32,463	$2.59M	0.0%	-80.2%	0.017%
2/17/2026	Amundi	20,067	$1.60M	0.0%	N/A	0.010%
2/17/2026	Farallon Capital Management LLC	14,582,796	$1.16B	5.5%	-0.3%	7.543%
2/17/2026	Price T Rowe Associates Inc. MD	3,404,717	$271.19M	0.0%	-12.1%	1.761%
2/17/2026	T. Rowe Price Investment Management Inc.	1,300,257	$103.57M	0.1%	-72.8%	0.673%
2/17/2026	Weiss Asset Management LP	30,022	$2.39M	0.0%	N/A	0.016%
2/17/2026	Osaic Holdings Inc.	20,430	$1.63M	0.0%	-7.7%	0.011%
2/17/2026	Integral Health Asset Management LLC	1,200,000	$95.58M	4.7%	+200.0%	0.621%
2/17/2026	Himension Capital Singapore PTE. LTD.	12,624	$1.01M	0.1%	-41.1%	0.007%
2/17/2026	Adage Capital Partners GP L.L.C.	2,205,555	$175.67M	0.3%	+197.1%	1.141%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $142.51

$142.08

$149.79

50 Day Range

MA: $113.41

$92.51

$152.54

52 Week Range

Now: $142.51

$34.00

$155.70

Volume

2,474,677 shs

Average Volume

4,662,699 shs

Market Capitalization

$30.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Rock Ventures Iii LP Third (Major Shareholder)
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Xiaolin Wang (Insider)
Lin Wei (Insider)
Margaret A Horn (Insider)
Lorence H Kim (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Bank of New York Mellon Corp — 0.30%
Candriam S.C.A. — 0.27%
Pictet Asset Management Holding SA — 0.28%
Lunate Capital Ltd — 0.28%
Swiss National Bank — 0.20%
Jennison Associates LLC — 0.14%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Lunate Capital Ltd
Pictet Asset Management Holding SA
Candriam S.C.A.
Zweig DiMenna Associates LLC
Bessemer Group Inc.
Sterling Capital Management LLC
California Public Employees Retirement System
Private Advisor Group LLC
In the last year, company insiders that have sold Revolution Medicines company stock include:
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Xiaolin Wang (Insider)
Lin Wei (Insider)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
Sumitomo Mitsui Trust Group Inc.
Swiss National Bank
Bank of New York Mellon Corp
SEB Asset Management AB
Fjarde AP Fonden Fourth Swedish National Pension Fund
Resona Asset Management Co. Ltd.
SG Americas Securities LLC
OP Asset Management Ltd